Studies of 3β-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin- stimulated Δ5-steroid levels

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 3961-3965

  Sakkal Alkaddour, Hala ^a   Zhang, Li ^a   Yang, Xiaojiang ^a   Chang, Ying T ^a   Kappy, Michael ^b   Slover, Robert S ^b   Jorgensen, Verena ^c   Pang, Songya ^a,d  

^a UNIVERSITY OF ILLINOIS   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 HYDROXYPREGNENOLONE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOTROPIN; PRASTERONE;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; GENE SEQUENCE; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; PATHOPHYSIOLOGY; PRECOCIOUS PUBERTY; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEROID BLOOD LEVEL;

17-ALPHA-HYDROXYPREGNENOLONE; 3-HYDROXYSTEROID DEHYDROGENASES; ADRENAL HYPERPLASIA, CONGENITAL; ADRENOCORTICOTROPIC HORMONE; ANDROSTENEDIONE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DEHYDROEPIANDROSTERONE; FEMALE; HUMANS; HYDROCORTISONE; INFANT; MALE; MUTATION; POLYMERASE CHAIN REACTION; PUBERTY, PRECOCIOUS;

EID: 0029798423     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.3961     Document Type: Article

References (25)

1. Pang S. 1996 Genetics of 3β-hydroxysteroid dehydrogenase deficiency. Growth, Genetics and Hormones. 12:6-10.
2. Rhéaume E, Simard J, Morel Y, et al. 1992 Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene. Nat Genet. 1:239-245.
3. Chang YT, Kappy MS, Iwamoto K, Wang J, Yang X, Pang S. 1993 Mutations in the type II 3β-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3β-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia. Pediatr Res. 34:698-700.
4. Simard J, Rheaume E, Leblanc JF, et al. 1994 Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273ΔAA in type II 3β-hydroxysteroid dehydrogenase gene (HSD 3/32) in three male patients of Afghan/Pakistani origin. Hum Mol Genet. 3:327-330.
5. Zhang L, Sakkal-Alkaddour H, Chang YT, Yang X, Pang S. 1995 A new compound heterozygous frameshift mutation in the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene causes salt-wasting 3β-HSD deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab. 81:291-295.
6. Simard J, Rheaume E, Sanchez R, et al. 1993 Molecular basis of congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency. Mol Endocrinol. 7:716-728.
7. Katsumata N, Tanae A, Yasunaga T, et al. 1995 A novel missense mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene in a family with classical salt-wasting congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency. Hum Mol Genet. 4:745-746.
8. Sanchez R, Mebarki F, Rheaume E, et al. 1994 Functional characterization of the novel L108W and P186L mutations detected in the type II 3 beta-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasia. Hum Mol Genet. 3:1639-1645.
9. Mendonca BB, Russell AJ, Vasconcelos-Leite M, et al. 1994 Mutation in 3β-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females. J Mol Endocrinol. 12:119-122.
10. Rhéaume E, Sanchez R, Simard J, et al. 1994 Molecular basis of congenital adrenal hyperplasia in two siblings with classical non salt-losing 3β-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 79:1012-1018.
11. Russell AJ, Wallace AM, Forest MG, Donaldson MDC, Edwards CRW, Sutcliffe RG. 1994 Mutation in the human gene for 3β-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss. J Mol Endocrinol. 12:225-237.
12. Sanchez R, Rheaume E, Laflamme N, Rosenfield RL, Labrie F, Simard J. 1994 Detection and functional characterization of the novel missense mutation Y254D in type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene of a female patient with non salt-losing 3β-HSD deficiency. J Clin Endocrinol Metab. 78:561-567.
13. Mèbarki F, Sanchez R, Rhéaume E, et al. 1995 Non salt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3β-hydroxysteroid dehydrogenase gene. J Clin Endocrinol Metab. 80:2127-2134.
14. Chang YT, Zhang L, Alkaddour HS, et al. 1995 Absence of molecular defect in the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3β-HSD activity. Pediatr Res. 37:820-824.
15. Riddick LM, Garibaldi LR, Wang ME, et al. 1991 3α-Androstanediol glucuronide in premature and normal pubarche. J Clin Endocrinol Metab. 72:46-50.
16. Lashansky G, Saenger P, Fishman K, et al. 1991 Normative data for adrenal steroidogenesis in a healthy pediatric population: age and sex-related changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab. 73:674-686.
17. 5-Δ4 isomerase gene: adrenal and gonadal specificity. DNA Cell Biol. 10:701-711.
18. Lorence MC, Corbin CJ, Kamimura N, Mahoondroo MS, Mason JI. 1990 Structural analysis of the gene encoding human 3β-hydroxysteroid dehydrogenase/ Δ5→4 isomerase. Mol Endocrinol. 4:1850-1855.
19. De Peretti E, Forest MG, Feit JP, David M. 1980 Endocrine studies in two children with male pseudohermaphroditism due to 3β-hydroxysteroid dehydrogenase defect. In: Gennazzani AR, et al, eds. Adrenal androgens. New York: Raven Press; 141-145.
20. Pang S, Levine LS, Stoner E, et al. 1983 Non salt-losing congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function. J Clin Endocrinol Metab. 56:808-818.
21. Zerah M, Rheaume E, Mani P, et al. 1994 No evidence of mutations in the genes for type I and type II 3β-hydroxysteroid dehydrogenase (3β-HSD) in nonclassical 3β-HSD deficiency. J Clin Endocrinol Metab. 79:1811-1817.
22. Kohn B, Levine LS, Pollack MS, et al. 1982 Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab. 55:817-827.
23. New MI, Lorenzen F, Lerner AJ, et al. 1983 Genotyping steroid 21-hydroxylase deficiency hormonal reference data. J Clin Endocrinol Metab. 57:320-326.
24. Barnes RB, Ehrmann DA, Brigell DF, Rosenfield RL. 1993 Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3β-hydroxy-Δ5-steroid dehydrogenase deficiency. J Clin Endocrinol Metab. 76:450-455.
25. Gonzalez F, Hatala DA, Speroff L. 1991 Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome. Am J Obstet Gynecol. 165:535-545.